HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 499224Generated: October 25, 2026
Sodium Hydroxide → 4-(1-Benzylpiperidin-3-yl)piperazine-1-carboxylic acid tert-butyl ester
https://huagongshe.com/reaction/499224
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | tert-Butyl piperazine-1-carboxylate | HCID 143452 | — |
| Reactant | 1-Benzylpiperidin-3-one hydrochloride hydrate | HCID 2760896 | — |
| Reactant | Sodium triacetoxyborohydride | HCID 5049666 | — |
| Solvent | 1,2-Dichloroethane | HCID 11 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | 4-(1-Benzylpiperidin-3-yl)piperazine-1-carboxylic acid tert-butyl ester | HCID 68455454 | 126.8% |
Reaction Steps
20 ml of a 10% sodium hydroxide solution are added to a suspension of 9.96 g of 1-benzyl-3-piperidone monohydrochloride hydrate in suspension in 200 ml of DCM. The medium is stirred, and the organic phase is separated by settling out and then washed with a saturated NaCl solution. After drying over MgSO4, the organic phase is concentrated. The gum obtained is taken up in 180 ml of DCE, 10.1 g of Boc-piperazine and then 15.9 g of NaBH(OAc)3 are added and the medium is stirred at AT for 12 h. The medium is concentrated and then taken up in EtOAc. The organic phase is washed twice with a saturated NaHCO3 solution, and then with a saturated NaCl solution. After drying over MgSO4, the organic phase is concentrated, to give 18.63 g of the expected product.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07767681B2 |
|---|
| Source dataset | uspto-grants-2010_08 |
|---|
| ORD ID | ord-87910c87bace45b09c20b3724529269b |
|---|
| Source note | uspto-grants-2010_08 |
|---|